Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Chubb
McKinsey
Accenture
Cantor Fitzgerald
Dow
Merck
UBS

Generated: May 22, 2018

DrugPatentWatch Database Preview

POLYMYXIN B SULFATE - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for polymyxin b sulfate and what is the scope of polymyxin b sulfate patent protection?

Polymyxin b sulfate
is the generic ingredient in six branded drugs marketed by Glaxosmithkline, Mylan Asi, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, West-ward Pharms Int, X Gen Pharms, Xellia Pharms Aps, Paddock Llc, Allergan, Akorn Inc, Bausch And Lomb, and Sandoz Inc, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for polymyxin b sulfate. Eight suppliers are listed for this compound.
Pharmacology for POLYMYXIN B SULFATE
Medical Subject Heading (MeSH) Categories for POLYMYXIN B SULFATE
Synonyms for POLYMYXIN B SULFATE
1405-20-5
1405-20-5, 4135-11-9 (free base)
405P205
AB00053527_02
AB2000085
AC1L1J4Z
AC1NWAPL
Aerosporin
Aerosporin, PMB, Poly-RX , 1405-20-5
Aerosporin, PMB, Poly-RX,Polymyxin B sulphate
Aerosporin;PMB;Poly-RX
AKOS015895662
AKOS025392172
AN-946
BSPBio_002197
C55H96N16O13.2H2SO4
CCG-39724
CHEMBL1200626
CHEMBL241797
D09OOV
DB00781
DivK1c_000732
FT-0654126
HFMDLUQUEXNBOP-OLYKAHIFSA-N
HFMDLUQUEXNBOP-UHFFFAOYSA-N
HMS1920J04
HMS2092A07
HMS502E14
I06-1086
I559
IDI1_000732
KBio1_000732
KBio2_001597
KBio2_004165
KBio2_006733
KBio3_001697
KBioGR_000961
KBioSS_001597
KS-1428
Listeria monocytogenes Selective Supplement I
M02428
MFCD00131991
MolPort-003-665-543
MolPort-035-783-496
N-[3-amino-1-({1-[(3-amino-1-{[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosan-21-yl]carbamoyl}propyl)carbamoyl]-2-hydroxypropyl}ca
N-[3-Amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carb
N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaketo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]p
N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]pr
N-[4-amino-1-[[1-[[4-amino-1-oxo-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobuta
NCGC00094763-01
NCGC00094763-02
NCGC00178768-01
NINDS_000732
NSC-757278
NSC757278
Pharmakon1600-01500492
Polimixina B
Poly-RX
Polymixin B sulfate, Cell Culture Reagent
Polymixin B sulphate
Polymixin B-sulfate
polymyxin b
Polymyxin B sulfate salt
Polymyxin B Sulfate, Bacillus polymyxa
Polymyxin B sulphate
Polymyxin B sulphate salt
Polymyxin-B-Sulfat
Polymyxine B
Polymyxine B (sulfate de)
Polymyxini B sulfas
Polymyxinum B
s1395
SBI-0051486.P003
SC-19217
SCHEMBL7799155
SPBio_000359
Spectrum_001117
SPECTRUM1500492
Spectrum2_000490
Spectrum3_000549
Spectrum4_000481
Spectrum5_001331
SR-05000002074
SR-05000002074-2
sufuric acid

US Patents and Regulatory Information for POLYMYXIN B SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 065006-001 Dec 17, 1998 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
X Gen Pharms POLY-RX polymyxin b sulfate POWDER;FOR RX COMPOUNDING 061578-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gland Pharma Ltd POLYMYXIN B SULFATE polymyxin b sulfate INJECTABLE;INJECTION 207322-001 Apr 14, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc TRIMETHOPRIM SULFATE AND POLYMYXIN B SULFATE polymyxin b sulfate; trimethoprim sulfate SOLUTION/DROPS;OPHTHALMIC 064211-001 Apr 13, 1998 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Cantor Fitzgerald
Argus Health
Citi
Teva
Cipla
US Army
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.